
Sign up to save your podcasts
Or


This program presents several expert perspectives on the latest immuno-oncology developments and how these advancements are impacting clinical practice.
This program has been developed with funding from
EMD Serono, Inc. and Merck KGaA, Darmstadt, Germany.
By ReachMD4.5
22 ratings
This program presents several expert perspectives on the latest immuno-oncology developments and how these advancements are impacting clinical practice.
This program has been developed with funding from
EMD Serono, Inc. and Merck KGaA, Darmstadt, Germany.

39 Listeners

10 Listeners

59 Listeners

1,150 Listeners

195 Listeners

45 Listeners

7 Listeners